Robocath
France - RouenBiotechnology
Focus: Robocath is a French biotech company specializing in robotic-assisted cardiovascular interventions, focusing on minimally invasive treatments for coronary and carotid artery diseases. With 51-200 employees, it operates as a niche player in the robotic surgery/medical device space within cardiovascular care.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
51-200
Open Jobs
0
About Robocath
AI assessmentNot HiringNo open roles listed right now. Follow Robocath to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Robotic-assisted Percutaneous Coronary Intervention
Stable
Clinical Development
Lead program targeting high-burden coronary intervention market with potential to differentiate through precision robotics.
Carotid Artery Stenting
Help build intelligence for Robocath
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.